Sponsor List - MarketsandMarkets BioGeNe Series 2023

MarketsandMarkets BioGeNe Series 2023

8th - 9th February 2023 | Double Tree by Hilton, San Diego - Mission Valley
Sponsors
Gold

Owlstone Medical

Owlstone Medical

Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by realizing the potential of breath biomarkers for early detection and precision medicine through Breath Biopsy®. Breath Biopsy provides reliable solutions for the collection and analysis of volatile organic compounds (VOCs) produced through metabolic processes or as a result of interaction with external factors such as diet or medication. Changes to exhaled VOCs can be associated with a range of disease conditions and environmental exposures.

 


Eremid Genomic Services

Eremid Genomic Services


Proteome Sciences

Proteome Sciences

We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry.  By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.

With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.

Silver

EpigenDx

EpigenDx

With over 15 years of experience in genetic and epigenetic clinical research, EpigenDx offers high quality products and laboratory services focused on DNA methylation analysis, gene expression profiling, and mutation analysis.  Our scientific teams carefully evaluate each project and establish analysis procedures using best fit technologies, including NGS, Pyrosequencing, RT-PCR, digital PCR, and GeneChip Microarray.  Our popular services include Line-1 global methylation tests and Foxp3-TSDR analysis for epigenetic immunotherapy.  Our GLP compliant and CLIA certified services make us the perfect partner during pre-clinical research and diagnostic test development.


BD Biosciences, USA

BD Biosciences, USA

Delivering innovative tools to basic and translational researchers. Our focus is directed towards advancing cellular analysis with flow cytometry cell analysers and sorters, fluorescently conjugated monoclonal antibodies as well as systems for single cell multiomics analysis. Bespoke antibody formulations, applications and assay design/development/optimization support as well as specific product training deliver holistic solutions to meet diverse customer needs.

Speaking Partner

GeneCentric Therapeutics, Inc.

GeneCentric Therapeutics, Inc.

GeneCentric Therapeutics, Inc. is an RNA-based genomic solutions provider based in Durham, North Carolina. The company designed its technologies to parse the complexity of tumor and immune biology using its RNA-based Tumor and Immune Micro-Environment (rT(I)ME) Explorer platform to discover and develop signatures of responder populations to oncology therapeutics. GeneCentric commercializes its technology through strategic collaborations with pharmaceutical, biotechnology and diagnostics companies in applications throughout preclinical testing, clinical drug development and commercialization lifecycle phases.


BioForm Solutions

BioForm Solutions

Bioform solutions has developed a robust assay to monitor the cell health of probiotics, regardless of strains or the matrix.  Flow cytometry is a single cell analysis tool.  It can enumerate bacteria or yeast, alone or in a mix.   It is the only way to enumerate heat killed cells (postbiotics) since they won’t grow.  CFUs have been used in the industry for decades due to no extra equipment or knowledge needed, but the data has a 30-50% variability which leads to large questions about its accuracy.  It also can only see cells that can grow in a particular media, so mixed strain probiotics can be very problematic.  When the cells become stressed out due to processing and packaging, they can become viable but not culturable (VBNC), which means they won’t grow in a CFU assay.  Flow cytometry gets around these issues by viewing all of the cells in a product, quickly and accurately with a CV <5%.  Flow cytometry takes ~15 minutes whereas the CFU assay takes 3 days.  This allows quick decisions to be made as a product is being formulated as well as determining the stability of the products. 

Exhibition Partner

Q2 Solutions

Q2 Solutions

Q2 Solutions is a leading global clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions. Q2 Solutions uses global experience, innovation and scientific expertise to transform science and data into medical insights that turn hope into help. A joint venture of IQVIA and Quest Diagnostics, Q2 Solutions leverages each parent organization’s clinical trials laboratory capabilities and treats each sample as if a life depends on it.


Pro Digest

Pro Digest

We are a dynamic pre-clinical CRO offering the best-in-class in vitro simulations of the gastrointestinal tract to the food, functional food, feed and pharma industry. We offer a broad range of solutions for in vitro simulation of the gastrointestinal tract. Our technology platforms cover the physiology of the upper gastrointestinal tract, the physiology and the microbiology of the lower gastrointestinal tract and the microbiome-host interactions, and range from high-throughput screenings (Colon-on-a-plate®) to in-depth simulation of the long-term impact using the SHIME®.

By sharing our expertise and using our technology platforms, we assist your product development by building up essential know-how in the field of gastrointestinal transit, digestion, bioaccessibility, bioavailability, targeted delivery, drug dissolution, metabolism, microbial fermentation activity, ileal and colonic microbiome, gut barrier integrity, inflammation, immunomodulation and efficacy of probiotics, prebiotics, functional ingredients and pharmaceuticals, in relation to their fate and function in the body.

Recently we expanded our scope with a new business unit, MetaKey®, completely dedicated to metabolomics. In addition to classical UHPLC-HRMS-based untargeted and targeted metabolomics services, MetaKey® offers an innovative LA-REIMS platform for screening based on metabolic fingerprinting, which enables a high throughput at an affordable cost. Applications include analysis of any kind of matrix, but with a particular focus on microbial metabolism and interactions of microbiota with the human body.

A strong team, the desire to innovate and our customers’ satisfaction are at the core of our DNA. Our long-standing expertise and tailor-made solutions support your research from early phases to the final stages of product development. Our long-standing experience and expertise in studying the gastrointestinal processes at your service!